More Information on 'Shuwen Biotech Co. Ltd.'

About Shuwen Biotech Co. Ltd.
Led by U.S. and European diagnostic industry veterans, Shuwen Biotech is engaged in licensing, developing, marketing and distributing innovative products and services for disease diagnosis and personalized medicine. The company strives to provide doctors and their patients with a comprehensive menu of the most innovative products and services for improved disease prediction, screening, diagnosis, prognosis and treatment in the areas of cancer, maternal fetal medicine, acute care, and preventive testing. Shuwen presently offers, in China, molecular diagnostic kits and LDT services for personalized medicine in oncology. Through international collaboration and in-licensing, we now have a pipeline of diagnostic assays based on patents and technologies licensed from some of the best research institutions and diagnostic companies in the U.S. and Europe. Our Capabilities Assay Development: Shuwen has an experienced team with expertise in diagnostic assay development and registration in China. Manufacturing: Shuwen has built its own diagnostic kit manufacturing facilities that meet regulatory requirements. LDT Service: We have the capabilities of developing LDTs and offering testing services through a CAP accredited reference lab. Marketing: Shuwen markets its diagnostic kits and services to physicians and patients in hospitals and pharmaceutical companies in their clinical trials through established marketing channels covering all of China, including the 300 largest hospitals. Partnerships While pursuing a comprehensive business strategy that emphasizes international collaboration and in-licensing, Shuwen strives to be the preferred partner in China for innovative diagnostic companies outside of China. We have the best capability in diagnostic patents, and have comprehensive IP strategies that will ensure the best return on both our investment and those of our licensors and partners.

Looking for Channel Partners in: